Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
BicycleTx Limited
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Edwards Lifesciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
National Cancer Institute (NCI)
Eli Lilly and Company
Bristol-Myers Squibb
Revolution Medicines, Inc.
NRG Oncology
USWM, LLC (dba US WorldMeds)
Aarhus University Hospital
Memorial Sloan Kettering Cancer Center
ARTBIO Inc.
AstraZeneca
Rutgers, The State University of New Jersey
Actuate Therapeutics Inc.
Modulation Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
Incyte Corporation
Mirati Therapeutics Inc.
Hoffmann-La Roche
Erasca, Inc.
AstraZeneca
Novartis
National Cancer Institute (NCI)
AstraZeneca
GlaxoSmithKline
Daiichi Sankyo
CHU de Quebec-Universite Laval
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Novartis
The Methodist Hospital Research Institute
University of Alabama at Birmingham
Boehringer Ingelheim